Cognitive function varies greatly throughout the day and night due to an intrinsic molecular clock localized hippocampal cells. In our last project period, we demonstrated that day-night differences in neuronal excitability, long-term potentiation, and memory are regulated by the circadian clock-controlled mechanisms such as kinase activation and ion channel regulation, and that excitability of central clock neurons in the suprachiasmatic nucleus is dysregulated in a mouse model of Alzheimer's disease. However, little is known about the underlying regulation of neuronal excitability by the molecular clock in hippocampus during both physiological and pathological states. Further investigation of the circadian regulation of passive and active membrane properties in excitatory pyramidal cells as well as inhibitory, parvalbumin-expressing interneurons is required to discover novel chronotherapeutic strategies for early intervention of hyper-excitability, cognitive dysfunction, and pathogenesis in Alzheimer's disease. In this competitive renewal request, we will test the novel hypotheses that the cell-autonomous molecular clock drives day-night differences in active and passive membrane properties of pyramidal neurons and PV+ interneurons at opposite times of the day. We predict that these anti-phase relationships promote day-night differences in excitatory-inhibitory balance, synaptic plasticity, and memory, and that disruption of circadian regulation of hippocampal membrane properties could contribute to hyper-excitability of the network and hasten cognitive impairment and pathogenesis. Using conditional transgenic mice, slice electrophysiology, bioluminescence imaging, chemogenetics, and behavioral assays, we will test whether rhythmic transcription and excitability of CA1 pyramidal neurons (Aim 1) and parvalbumin-expressing interneurons (Aim 2) are driven by the molecular clock and necessary for day-night differences in memory and plasticity.
Aim 3 will use chemogenetics to determine whether restoration of day- night differences in the depolarization state and intrinsic excitability of CA1 pyramidal neurons is protective against Alzheimer's disease pathology and memory impairment. Altogether, these experiments have the potential to reveal an entirely novel mechanism by which the hippocampal clock regulates day-night differences in plasticity and cognition and could give critical insight into Alzheimer's disease hyperexcitability, memory impairment, and pathogenesis.

Public Health Relevance

The mechanisms underlying day-night differences in cognition and memory are unclear. This proposal investigates the novel hypothesis that the cellular circadian clock is critical for regulation of neural activity at the appropriate time-of-day in different types of neurons in the brain region that controls memory. As a result, targeting hyperactivity in nerve cells at a specific time of day in early Alzheimer's disease may provide a neuroprotective strategy to reduce pathogenesis and prevent memory loss.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS082413-06
Application #
9522634
Study Section
Neurodifferentiation, Plasticity, and Regeneration Study Section (NDPR)
Program Officer
He, Janet
Project Start
2013-03-15
Project End
2023-03-31
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
6
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Psychiatry
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Paul, Jodi R; Munir, Hira A; van Groen, Thomas et al. (2018) Behavioral and SCN neurophysiological disruption in the Tg-SwDI mouse model of Alzheimer's disease. Neurobiol Dis 114:194-200
Besing, Rachel C; Rogers, Courtney O; Paul, Jodi R et al. (2017) GSK3 activity regulates rhythms in hippocampal clock gene expression and synaptic plasticity. Hippocampus 27:890-898
Paul, Jodi R; McKeown, Alex S; Davis, Jennifer A et al. (2017) Glycogen synthase kinase 3 regulates photic signaling in the suprachiasmatic nucleus. Eur J Neurosci 45:1102-1110
Albers, H Elliott; Walton, James C; Gamble, Karen L et al. (2017) The dynamics of GABA signaling: Revelations from the circadian pacemaker in the suprachiasmatic nucleus. Front Neuroendocrinol 44:35-82
Paul, Jodi R; DeWoskin, Daniel; McMeekin, Laura J et al. (2016) Regulation of persistent sodium currents by glycogen synthase kinase 3 encodes daily rhythms of neuronal excitability. Nat Commun 7:13470
Davis, Jennifer A; Gamble, Karen L (2016) Synchronized time-keeping is key to healthy mood regulation (Commentary on Landgraf et al.). Eur J Neurosci 43:1307-8
Peliciari-Garcia, Rodrigo A; Goel, Mehak; Aristorenas, Jonathan A et al. (2016) Altered myocardial metabolic adaptation to increased fatty acid availability in cardiomyocyte-specific CLOCK mutant mice. Biochim Biophys Acta 1861:1579-95
McMeekin, Laura J; Lucas, Elizabeth K; Meador-Woodruff, James H et al. (2016) Cortical PGC-1?-Dependent Transcripts Are Reduced in Postmortem Tissue From Patients With Schizophrenia. Schizophr Bull 42:1009-17
Hablitz, Lauren M; Molzof, Hylton E; Abrahamsson, Kathryn E et al. (2015) GIRK Channels Mediate the Nonphotic Effects of Exogenous Melatonin. J Neurosci 35:14957-65
Udoh, Uduak S; Swain, Telisha M; Filiano, Ashley N et al. (2015) Chronic ethanol consumption disrupts diurnal rhythms of hepatic glycogen metabolism in mice. Am J Physiol Gastrointest Liver Physiol 308:G964-74

Showing the most recent 10 out of 17 publications